- Home
- WHLR vs DRMA Comparison
WHLR vs DRMA Comparison
Compare WHLR & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- DRMA
- Stock Information
- Founded
- WHLR 2011
- DRMA 2014
- Country
- WHLR United States
- DRMA United States
- Employees
- WHLR N/A
- DRMA N/A
- Industry
- WHLR Real Estate Investment Trusts
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- DRMA Health Care
- Exchange
- WHLR Nasdaq
- DRMA Nasdaq
- Market Cap
- WHLR 1.4M
- DRMA 1.7M
- IPO Year
- WHLR 2012
- DRMA 2021
- Fundamental
- Price
- WHLR $6.31
- DRMA $1.10
- Analyst Decision
- WHLR
- DRMA Strong Buy
- Analyst Count
- WHLR 0
- DRMA 1
- Target Price
- WHLR N/A
- DRMA $6.00
- AVG Volume (30 Days)
- WHLR 209.5K
- DRMA 85.2K
- Earning Date
- WHLR 11-07-2024
- DRMA 11-13-2024
- Dividend Yield
- WHLR N/A
- DRMA N/A
- EPS Growth
- WHLR N/A
- DRMA N/A
- EPS
- WHLR N/A
- DRMA N/A
- Revenue
- WHLR $102,749,000.00
- DRMA N/A
- Revenue This Year
- WHLR N/A
- DRMA N/A
- Revenue Next Year
- WHLR N/A
- DRMA N/A
- P/E Ratio
- WHLR N/A
- DRMA N/A
- Revenue Growth
- WHLR N/A
- DRMA N/A
- 52 Week Low
- WHLR $2.90
- DRMA $1.11
- 52 Week High
- WHLR $1,410.48
- DRMA $13.35
- Technical
- Relative Strength Index (RSI)
- WHLR 37.42
- DRMA 32.60
- Support Level
- WHLR $6.81
- DRMA $1.22
- Resistance Level
- WHLR $7.87
- DRMA $1.54
- Average True Range (ATR)
- WHLR 0.79
- DRMA 0.11
- MACD
- WHLR -0.04
- DRMA -0.02
- Stochastic Oscillator
- WHLR 8.73
- DRMA 3.53
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.